Nuclear magnetic resonance-based metabolomics predicts exercise-induced ischemia in patients with suspected coronary artery disease

Magnetic Resonance in Medicine

Volumn 60, Issue 1, 2008, Pages 27-32

  Barba, Ignasi ^a   De León, Gustavo ^a   Martín, Eva ^a   Cuevas, Antonio ^b   Aguade, Santiago ^a   Candell Riera, Jaume ^a   Barrabés, José A ^a   Garcia Dorado, David ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Coronary artery disease; Ischemia; Metabolomics; Stress test; Systems biology

Indexed keywords

CARDIOLOGY; COMPLEXATION; DIAGNOSIS; DISCRIMINANT ANALYSIS; DISEASES; FORECASTING; HEART; METABOLITES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE BEAMS; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; SMOKE;

CORONARY ARTERY DISEASE; ISCHEMIA; METABOLOMICS; STRESS TEST; SYSTEMS BIOLOGY;

NUCLEAR MAGNETIC RESONANCE;

AMINO ACID; DIPYRIDAMOLE; GLUCOSE; LACTIC ACID; LIPID;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; DIAGNOSTIC VALUE; DISCRIMINANT ANALYSIS; EXERCISE; EXERCISE INDUCED ISCHEMIA; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE; PROSPECTIVE STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; REGRESSION ANALYSIS; RELAXATION TIME; RISK FACTOR; SCREENING TEST; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMOKING;

EID: 46849088403     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21632     Document Type: Article

References (22)

1. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB Jr, Fihn SD, Fraker TD Jr, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 2003;41:159-168.
2. The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Guidelines on the management of stable angina pectoris: executive summary. Eur Heart J 2006;27:1341-1381.
3. 1H-NMR-based metabonomics. Nat Med 2002;8:1439-1445 [erratum, Nat Med 2003;9:477].
4. Kirschenlohr HL, Griffin JL, Clarke SC, Rhydwen R, Grace AA, Schofield PM, Brindle KM, Metcalfe JC. Proton NMR analysis of plasma is a weak predictor of coronary artery disease. Nat Med 2006;12:705-710 [erratum, Nat Med 2006;12:862].
5. Sabatine MS, Liu E, Morrow DA, Heller E, McCarroll R, Wiegand R, Berriz GF, Roth FP, Gerszten RE. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 2005;112:3868-3875.
6. 99mTc-MIBI SPECT: improved diagnostic yield in coronary artery disease. J Am Coll Cardiol 1997;29:531-536.
7. Committee on Advanced Cardiac Imaging and Technology, Council on Clinical Cardiology, American Heart Association; Cardiovascular Imaging Committee, American College of Cardiology; and Board of Directors, Cardiovascular Council, Society of Nuclear Medicine. Standardization of cardiac tomographic imaging. Circulation 1992;86:338-339.
8. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, Van Train KF, Berman DS. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995;36:2138-2147.
9. Sklenar V, Piotto M, Leppik R, Saudek V. Gradient-tailored water suppression for 1H-15N HSQC experiments optimized to retain full sensitivity. J Magn Reson Ser A, 1993;102:241-245.
10. Homans SW. A dictionary of concepts in NMR, revised edition. Oxford: Clarendon Press; 1993:310-314.
11. Frank IE, Friedman JH. A statistical review of some chemometrics regression tools. Technometrics 1993;35:109-148.
12. Barker M, Rayens W. Partial least squares for discrimination. J Chemometrics 2003;17:166-173.
13. Efron B. The efficiency of logistic regression compared to normal discriminant analysis. J Am Stat Assoc 1975;70:892-898.
14. Hastie T, Tibshirani R, Friedman JH. The elements of statistical learning: data mining, inference, and prediction. New York: Springer; 2001:9.
15. Boulesteix AL. PLS dimension reduction for classification with microarray data. Stat Appl Genet Mol Biol 2004;3:Article33.
16. 1H nuclear magnetic resonance spectra of human urine from normal and pathologic states. Anal Biochem 1994;220:284-296.
17. Tate AR, Crabb S, Griffiths JR, Howells SL, Mazucco RA, Rodrigues LM, Watson D. Lipid metabolite peaks in pattern recognition analysis of tumour in vivo MR spectra. Anticancer Res 1996;16:1575-1579.
18. Tinsley J, Deconinck N, Fisher R, Kahn D, Phelps S, Gillis JM, Davies K. Expression of full-length urotrophin prevents muscular dystrophy in mdx mice. Nat Med 1998;4:1441-1444.
19. Raamsdonk LM, Teusink B, Broadhurst D, Zhang N, Hayes A, Walsh MC, Berden JA, Brindle KM, Kell DB, Rowland JJ, Westerhoff HV, van Dam K, Oliver SG. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nat Biotechnol 2001;19:45-50.
20. Griffin JL, Sang E, Evens T, Davies K, Clarke K. Metabolic profiles of dystrophin and urotrophin expression in mouse models of Duchenne muscular dystrophy. FEBS Lett 2002;530:109-116.
21. Ippolito JE, Xu J, Jain S, Moulder K, Mennerick S, Crowley JR, Townsend RR, Gordon JI. An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers. Proc Natl Acad Sci U S A 2005;102:9901-9906.
22. Schnackenberg LK, Beger RD. Monitoring the health to disease continuum with global metabolic profiling and systems biology. Pharmacogenomics 2006;7:1077-1086.